trastuzumab deruxtecan,sacituzumab
daiichi sankyo,astrazeneca,gilead sciences
['breast', 'destiny,breast,2', 'destiny,breast,4', 'tropics-02']
#esmo22: pros from the destiny-breast04 and tropics-02 trials support the use of adcs in patients with metastatic #breastcancer 
The European Society for Medical Oncology (ESMO) is the leading organisation for cancer education and information, supporting the oncology community’s work.